Caption Management, LLC Macrogenics Inc Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $113,864 - $636,744	34,400 New	34,400 $146,000
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $49,388 - $103,213	14,787 New	14,787 $99,000
Q4 2021 Feb 11, 2022	SELL	$15.91 - $21.88 $1.43 Million - $1.97 Million	-90,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$19.74 - $28.7 $14,844 - $21,582	752 Added 0.84%	90,000 $1.89 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $199,306 - $346,573	-9,727 Reduced 9.83%	89,248 $2.4 Million
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $1.88 Million - $3.29 Million	98,975 New	98,975 $3.15 Million
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $128,400 - $363,300	-30,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$7.95 - $12.27 $397,500 - $613,500	-50,000 Reduced 62.5%	30,000 $327,000
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $870,800 - $1.22 Million	70,000 Added 700.0%	80,000 $1.02 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $111,100 - $256,000	10,000 New	10,000 $180,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.